Comparative Analysis of Dynamic Cell Viability, Migration and Invasion Assessments by Novel Real-Time Technology and Classic Endpoint Assays

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Limame, Ridha ^a   Wouters, An ^a   Pauwels, Bea ^a   Fransen, Erik ^a   Peeters, Marc ^a,b   Lardon, Filip ^a   de Wever, Olivier ^c   Pauwels, Patrick ^a,b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL; CANCER CELL CULTURE; CANCER INVASION; CELL ASSAY; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IMPEDANCE; LUNG ADENOCARCINOMA; MICROELECTRODE; NON INVASIVE PROCEDURE; OPTICAL DENSITY; REAL TIME CELL ANALYSIS;

ANTINEOPLASTIC AGENTS; BIOLOGICAL ASSAY; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; COLLAGEN; DIFFUSION CHAMBERS, CULTURE; DRUG COMBINATIONS; ELECTRIC IMPEDANCE; ENDPOINT DETERMINATION; FEMALE; GENTIAN VIOLET; HUMANS; LAMININ; PACLITAXEL; PROTEOGLYCANS; REPRODUCIBILITY OF RESULTS; RHODAMINES; SENSITIVITY AND SPECIFICITY;

EID: 84867676788     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046536     Document Type: Article

References (17)

1. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674 doi:10.1016/j.cell.2011.02.013.
2. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, et al. (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82: 1107-1112.
3. Friedl P, Gilmour D, (2009) Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol 10: 445-457 doi:10.1038/nrm2720.
4. Roussos ET, Condeelis JS, Patsialou A, (2011) Chemotaxis in cancer. Nat Rev Cancer 11: 573-587 doi:10.1038/nrc3078.
5. Friedl P, Wolf K, (2003) Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3: 362-374 doi:10.1038/nrc1075.
6. Hulkower KI, Herber RL, (2011) Cell Migration and Invasion Assays as Tools for Drug Discovery. Pharmaceutics 3: 107-124 doi:10.3390/pharmaceutics3010107.
7. BOYDEN S, (1962) The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med 115: 453-466.
8. Ke N, Wang X, Xu X, Abassi YA, (2011) The xCELLigence system for real-time and label-free monitoring of cell viability. Methods Mol Biol 740: 33-43 doi:10.1007/978-1-61779-108-6_6.
9. Atienza JM, Yu N, Kirstein SL, Xi B, Wang X, et al. (2006) Dynamic and label-free cell-based assays using the real-time cell electronic sensing system. Assay Drug Dev Technol 4: 597-607 doi:10.1089/adt.2006.4.597.
10. Vichai V, Kirtikara K, (2006) Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc 1: 1112-1116 doi:10.1038/nprot.2006.179.
11. Abassi YA, Xi B, Zhang W, Ye P, Kirstein SL, et al. (2009) Kinetic Cell-Based Morphological Screening: Prediction of Mechanism of Compound Action and Off-Target Effects. Chem Biol 16: 712-723 doi:10.1016/j.chembiol.2009.05.011.
12. Romano P, Manniello A, Aresu O, Armento M, Cesaro M, et al. (2009) Cell Line Data Base: structure and recent improvements towards molecular authentication of human cell lines. Nucleic Acids Res 37: D925-D932 doi:10.1093/nar/gkn730.
13. Pauwels B, Korst AEC, de Pooter CMJ, Lambrechts HAJ, Pattyn GGO, et al. (2003) The radiosensitising effect of gemcitabine and the influence of the rescue agent amifostine in vitro. Eur J Cancer 39: 838-846.
14. Pauwels B, Korst AEC, De Pooter CMJ, Pattyn GGO, Lambrechts HAJ, et al. (2003) Comparison of the sulforhodamine B assay and the clonogenic assay for in vitro chemoradiation studies. Cancer Chemother Pharmacol 51: 221-226 doi:10.1007/s00280-002-0557-9.
15. Zhang D, LaFortune TA, Krishnamurthy S, Esteva FJ, Cristofanilli M, et al. (2009) Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Reverses Mesenchymal to Epithelial Phenotype and Inhibits Metastasis in Inflammatory Breast Cancer. Clinical Cancer Research 15: 6639-6648 doi:10.1158/1078-0432.CCR-09-0951.
16. de Wever O, Hendrix A, de Boeck A, Westbroek W, Braems G, et al. (2010) Modeling and quantification of cancer cell invasion through collagen type I matrices. Int J Dev Biol 54: 887-896 doi:10.1387/ijdb.092948ow.
17. Huang J, Bridges LC, White JM, (2005) Selective modulation of integrin-mediated cell migration by distinct ADAM family members. Mol Biol Cell 16: 4982-4991 doi:10.1091/mbc.E05-03-0258.